1-4 of 4
Rosemarie Schobess, MD
Close
Sort by
Journal Articles

Impact of Treatment Intensity and Factor VIII Products On the Development On High Titre Inhibitors in Children with Severe Hemophilia A: Results of a Non-Concurrent Cohort Study.

Karin Kurnik, MD, Susan Halimeh, MD, Daniela Manner, MD, Susanne Holzhauer, MD, Carmen Escuriola Ettingshausen, MD, Rosemarie Schobess, MD, Ulrike Nowak-Gottl, MD
Journal: Blood
Blood (2009) 114 (22): 1303.
https://doi.org/10.1182/blood.V114.22.1303.1303
Published: 2009
Journal Articles

European Collaborative Paediatric Database on Cerebral Venous Thrombosis: Risk Factors for Recurrent Venous Thromboembolism.

Gili Kenet, MD, Fenella Kirkham, MD, Thomas Niederstadt, MD, Karin Kurnik, MD, Rosemarie Schobess, MD, Ralf Knofler, MD, Barbara Zieger, MD, Ulrike Nowak-Gottl, MD
Journal: Blood
Blood (2006) 108 (11): 276.
https://doi.org/10.1182/blood.V108.11.276.276
Published: 2006
Journal Articles

Long-Term Safety and Efficacy Data on Childhood Venous Thrombosis Treated with Enoxaparin: An Open Label Survey of Once-Daily Versus Twice-Daily Administration.

Ulrike Nowak-Gottl, MD, Christine During, MD, Christoph Bidlingmaier, MD, Nick Merkel, MD, Rosemarie Schobess, MD
Journal: Blood
Blood (2005) 106 (11): 549.
https://doi.org/10.1182/blood.V106.11.549.549
Published: 2005
Journal Articles

Factor V G1691A and Factor II G20210A Mutations and Clinical Expression of Severe Hemophilia A (< 2%) in Children: Impact on Bleeding Episodes and Joint Damage.

Ulrike Nowak-Gottl, MD, Carmen Escuriola, MD, Rosemarie Schobess, MD, Christine Duering, MD, Christoph Bidlingmaier, MD, Hartmut Pollmann, MD, Sylvia Horneff, MD, Karin Kurnik, MD
Journal: Blood
Blood (2004) 104 (11): 3095.
https://doi.org/10.1182/blood.V104.11.3095.3095
Published: 2004